TY - JOUR
T1 - A cyclic GMP-dependent housekeeping Cl- channel in rabbit gastric parietal cells activated by a vasodilator ecabapide
AU - Sakai, Hideki
AU - Ikari, Akira
AU - Kumano, Eiichi
AU - Takeguchi, Noriaki
PY - 1996
Y1 - 1996
N2 - 1. The membrane potential of rabbit gastric parietal cells is dominated by a Cl- channel with a subpicosiemens single channel conductance in the basolateral membrane. The effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]amino-N- methylbenzamide (DQ-2511: ecabapide), a vasodilator, on the opening of this Cl- channel, the cyclic GMP content and the intracellular free Ca2+ concentration ([Ca2+](i)) of parietal cells were investigated by whole-cell patch-clamp technique, enzyme immunoassay and Fura 2-fluorescence measurement. 2. Ecabapide stimulated the opening of the Cl- channel as determined by the reversal potential. This stimulation was concentration-dependent, and its EC50 value was 0.2 μM. Both the basal and ecabapide-induced openings of the channel were inhibited by 5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB, 500 μM), a Cl- channel blocker. Another Cl- channel blocker, niflumic acid (500 μM) was much less effective. 3. The power spectra of the currents before and after the addition of ecabapide (10 μM) were analysed. Both spectra contained only one Lorentzian (1/f2) component. 4. 6-Anilino-5,8-quinolinedione (LY83583; 5 μM), which prevents activation of soluble guanylate cyclase, significantly inhibited both the basal and ecabapide (10 μM)-induced openings of the Cl- channel. 5. Ecabapide (0.01-100 μM) concentration-dependently elevated the cyclic GMP content in the parietal cell-rich suspension. The EC50 value was 0.2 μM. 6. In single Fura 2-loaded parietal cells, ecabapide (10-100 μM) did not increase [Ca2+](i). 7. These results indicate that ecabapide stimulates an intracellular production of cyclic GMP in the parietal cell without increasing [Ca2+](i), and leads to an activation of the housekeeping Cl- channel.
AB - 1. The membrane potential of rabbit gastric parietal cells is dominated by a Cl- channel with a subpicosiemens single channel conductance in the basolateral membrane. The effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]amino-N- methylbenzamide (DQ-2511: ecabapide), a vasodilator, on the opening of this Cl- channel, the cyclic GMP content and the intracellular free Ca2+ concentration ([Ca2+](i)) of parietal cells were investigated by whole-cell patch-clamp technique, enzyme immunoassay and Fura 2-fluorescence measurement. 2. Ecabapide stimulated the opening of the Cl- channel as determined by the reversal potential. This stimulation was concentration-dependent, and its EC50 value was 0.2 μM. Both the basal and ecabapide-induced openings of the channel were inhibited by 5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB, 500 μM), a Cl- channel blocker. Another Cl- channel blocker, niflumic acid (500 μM) was much less effective. 3. The power spectra of the currents before and after the addition of ecabapide (10 μM) were analysed. Both spectra contained only one Lorentzian (1/f2) component. 4. 6-Anilino-5,8-quinolinedione (LY83583; 5 μM), which prevents activation of soluble guanylate cyclase, significantly inhibited both the basal and ecabapide (10 μM)-induced openings of the Cl- channel. 5. Ecabapide (0.01-100 μM) concentration-dependently elevated the cyclic GMP content in the parietal cell-rich suspension. The EC50 value was 0.2 μM. 6. In single Fura 2-loaded parietal cells, ecabapide (10-100 μM) did not increase [Ca2+](i). 7. These results indicate that ecabapide stimulates an intracellular production of cyclic GMP in the parietal cell without increasing [Ca2+](i), and leads to an activation of the housekeeping Cl- channel.
KW - Cl channel
KW - Cyclic GMP
KW - Ecabapide
KW - Guanylate cyclase
KW - Intracellular Ca concentration
KW - Parietal cell
KW - Rabbit stomach
UR - http://www.scopus.com/inward/record.url?scp=0030465338&partnerID=8YFLogxK
U2 - 10.1111/j.1476-5381.1996.tb16077.x
DO - 10.1111/j.1476-5381.1996.tb16077.x
M3 - 学術論文
C2 - 8982506
AN - SCOPUS:0030465338
SN - 0007-1188
VL - 119
SP - 1591
EP - 1599
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 8
ER -